Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?

@article{Lader1999LimitationsOT,
  title={Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?},
  author={Malcolm Harold Lader},
  journal={European Neuropsychopharmacology},
  year={1999},
  volume={9},
  pages={S399-S405}
}
  • M. Lader
  • Published 1 December 1999
  • Psychology, Medicine
  • European Neuropsychopharmacology
Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
TLDR
Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation, and both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed.
Current issues in the use of benzodiazepines for the treatment of insomnia
TLDR
Current evidence for the rational use of benzodiazepines is reviewed, as relevant data are scanty and relapse, rebound and dependence on withdrawal not clearly distinguished.
Benzodiazepines and anxiety disorders: a review for the practicing physician
TLDR
BZDs remain a mainstay in the treatment of anxiety, as both monotherapy and adjunctive therapy, and factors to consider prior to prescribing a BZD include the patient's diagnosis, as well as drug characteristics, including the potential for interactions with other drugs, the risk of dependence and withdrawal, and the required frequency of dosing.
Safety and Efficacy of Herbal Sedatives in Cancer Care
TLDR
Although sufficient evidence exists to recommend some of these agents for short-term relief of mild insomnia, long-term trials and observational studies are needed to establish the safety of prolonged use as well as overall efficacy in the context of cancer treatment and management.
Benzodiazepines revisited--will we ever learn?
  • M. Lader
  • Medicine, Psychology
    Addiction
  • 2011
TLDR
A series of adverse effects that continued to cause concern were noted, such as cognitive and psychomotor impairment, and dependence and abuse remain as serious problems despite warnings and guidelines.
[Evaluation of the medical orientation for the benzodiazepine side effects].
TLDR
It is suggested that physicians were worried about the alcohol interaction risk, which can be dangerous for the patients, and the quality of the medical directions given to patients about benzodiazepines side effects was precarious.
Factors Associated with Long-Term Use of Hypnotics among Patients with Chronic Insomnia
TLDR
It is revealed that a high PSQI score at the baseline, particularly in the sub-items relating to sleep maintenance disturbance, is predictive of long-term hypnotic treatment.
The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic Study
  • Sheng-Min WangJung-Bum Kim Kyoung-Uk Lee
  • Psychology, Medicine
    Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2016
TLDR
It is suggested that clonazepam is as efficacious as other benzodiazepines for the treatment of various anxiety disorders and the safety profile of clonazerepam was superior to the other Benzodiazepine groups in this study.
The use of benzodiazepines in palliative care
TLDR
A relatively high proportion of patients was prescribed benzodiazepines, and most administration occurred within the last three weeks of life in response to symptoms of anxiety or less specific distress.
...
...

References

SHOWING 1-10 OF 30 REFERENCES
The drug treatment of anxiety.
  • J. Rosenbaum
  • Psychology, Medicine
    The New England journal of medicine
  • 1982
TLDR
The therapeutic benefits obtained from antianxiety medication, weighed against the adverse effects, have been a matter of considerable public controversy and more rigorous and extensive surveys have concluded that reckless overprescribing is rare and that these agents are relatively safe.
Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta‐analysis
  • W. Boyer
  • Psychology
    International clinical psychopharmacology
  • 1995
TLDR
The superiority of the serotonin reuptake inhibitors remained, but was less pronounced, when they were compared to the studies which used higher doses of imipramine or alprazolam, and indirectly add the evidence that serotonergic abnormalities may have a role in its etiology.
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy.
TLDR
Stimulus control and sleep restriction were the most effective single therapy procedures, whereas sleep hygiene education was not effective when used alone.
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
TLDR
There was a significant increase in symptom severity consistent with a withdrawal reaction for the clorazepate group but not the buspirone group, and there was a suggestion that previous discontinuous exposure to benzodiazepines might sensitize patients to subsequent withdrawal effects.
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
TLDR
Alprazolam was found to be effective and well tolerated in patients with agoraphobia with panic attacks and panic disorder and significantly more placebo recipients subsequently dropped out of the trial, primarily citing ineffectiveness of placebo as the reason.
Treatment Outlines for the Management of Anxiety States
  • G. Andrews
  • Psychology, Medicine
    The Australian and New Zealand journal of psychiatry
  • 1985
TLDR
The Quality Assurance Project is developing explicit and detailed treatment outlines for each of the major psychiatric disorders, with behaviour therapy—cognitive anxiety management, relaxation and hyperventilation control—being recommended as an essential adjunct to drug therapy.
Lorazepam in the elderly—a retrospective study of the side-effects in 20 patients
TLDR
It is concluded that there are insufficient data to recommend lorazepam over any other agent in the elderly and care should always be exercised when prescribing in older patients.
Psychological Treatment of Generalised Anxiety Disorder
TLDR
A balanced appraisal of the value of psychological therapy with this common condition requires a fuller description of sample characteristics and more systematic investigation of the clinical significance of treatment effects over the long term.
Long-term diazepam therapy and clinical outcome.
TLDR
It is indicated that a significant number of patients benefit from prolonged diazepam treatment and that tolerance to the anxiolytic effect of diazepAM does not develop during a 22-week study period.
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
TLDR
It is recommended that patients with panic disorder be treated for a longer period, at least six months, and that medication be tapered over a more prolonged period, for at least eight weeks, especially where high doses are employed.
...
...